Proposed Collection; 60-Day Comment Request; Federally Funded Research Development Center Contract Administration System (FCAS) Vendor Portal National Cancer Institute (NCI), 47970-47971 [2024-12203]
Download as PDF
<![CDATA[
47970
Federal Register / Vol. 89, No. 108 / Tuesday, June 4, 2024 / Notices
Dated: May 29, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–12133 Filed 6–3–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Sex
Differences in AD.
Date: July 9, 2024.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging, 5601
Fishers Lane, Rockville, MD 20852. (Virtual
Meeting).
Contact Person: Dario Dieguez, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institutes of Health,
National Institute on Aging, 5601 Fishers
Lane, Rockville, MD 20852, (301) 827–3101,
dario.dieguez@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: May 29, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–12134 Filed 6–3–24; 8:45 am]
ddrumheller on DSK120RN23PROD with NOTICES1
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
17:15 Jun 03, 2024
Jkt 262001
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel NST–2 SEP.
Date: June 25, 2024.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: DeAnna Lynn Adkins,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, NINDS/NIH/HHS NSC, 6001
Executive Boulevard, Rockville, MD 20852,
301–496–9223, deanna.adkins@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: May 29, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–12136 Filed 6–3–24; 8:45 am]
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; National
Institute on Deafness and Other
Communication Disorders Special Emphasis
Panel.
Date: June 18, 2024.
Time: 11:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Andrea B. Kelly, Ph.D.,
Scientific Review Officer, National Institute
on Deafness and Other Communication
Disorders, National Institutes of Health, 6001
Executive Boulevard, Room 8351, Bethesda,
MD 20892, (301) 451–6339, kellya2@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: May 30, 2024.
Patricia B. Hansberger,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–12176 Filed 6–3–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Federally Funded Research
Development Center Contract
Administration System (FCAS) Vendor
Portal National Cancer Institute (NCI)
BILLING CODE 4140–01–P
AGENCY:
National Institutes of Health,
HHS.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide
opportunity for public comment on
proposed data collection projects, the
National Institutes of Health, National
Cancer Institute (NCI) will publish
periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
SUMMARY:
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\04JNN1.SGM
04JNN1
47971
Federal Register / Vol. 89, No. 108 / Tuesday, June 4, 2024 / Notices
contact: Scott Keasey, 428 Miller Drive,
Suite 59 9742, Rockville, MD 20880 or
call non-toll-free number 301–846–1115
or Email your request, including your
address to: scott.keasey@nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
SUPPLEMENTARY INFORMATION:
FCAS Vendor Portal which is in
production. To streamline processes,
increase transparency and gain
efficiencies, the OA the FCAS vendor
portal to replace processes that are
handled through email FCAS Vendor
Portal Users to individual OA
recipients. The FCAS Vendor Portal will
serve as a one-stop shop for
transmission of requests, reports,
deliverables and other correspondence
due on numerous research and
development, in support of R&D
contracts as well as those contract
vehicles awarded using various Federal
Acquisition Procedures including but
not limited to FAR Part 8, Required
Sources of Supplies and Services, FAR
Part 13, Simplified Acquisition
Procedures, and FAR Part 12,
Acquisition of Commercial Items. These
reports and deliverables cover a wide
variety of topics in the areas of cancer
research including prevention,
detection, diagnosis, and control.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
77.
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Proposed Collection Title: Federally
Funded Research Development Center
Contract Administration System (FCAS)
Vendor Portal National Cancer Institute
(NCI), 0925–0773, Expiration Date 10/
31/2024, REVISION, National Cancer
Institute (NCI), National Institutes of
Health (NIH).
Need and Use of Information
Collection: The National Cancer
Institute (NCI) Office of Acquisitions
(OA) located within the Office of the
Director (OD) in the Office of
Management (OM) at the National
Cancer Institute (NCI), awards and
administers contracts and simplified
acquisitions in support of the Institute’s
mission to prevent, diagnose and treat
cancer. During the acquisition process,
the OA ensures that customer service is
paramount, and communications are
open and continuous. Currently
requests and correspondence are sent to
and received from vendors through
email with the exception of the FFRDC
Contractor who submits through the
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average time
per response
(in hours)
Total annual
burden hours
Type of respondent
Survey ...............................................
Registration .......................................
Data Field Information ......................
Add/Edit new Vendor ........................
Individuals ........................................
Corporations .....................................
Individuals ........................................
Corporations .....................................
1
1
72
6
1
1
63
1
6/60
6/60
1/60
6/60
0
0
76
1
Totals .........................................
...........................................................
80
4,544
........................
77
Dated: May 30, 2024.
Diane Kreinbrink,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.
[FR Doc. 2024–12203 Filed 6–3–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Number of
respondents
Form name
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
VerDate Sep<11>2014
17:15 Jun 03, 2024
Jkt 262001
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
(Catalogue of Federal Domestic Assistance
Program No. 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of Mosaic K99 applications.
Date: July 10, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Lee Warren Slice, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN12, Bethesda,
Maryland 20892, 301–435–0807, slicelw@
mail.nih.gov.
[FR Doc. 2024–12210 Filed 6–3–24; 8:45 am]
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
Dated: May 30, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
E:\FR\FM\04JNN1.SGM
04JNN1
]]>Agencies
[Federal Register Volume 89, Number 108 (Tuesday, June 4, 2024)]
[Notices]
[Pages 47970-47971]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-12203]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request; Federally Funded
Research Development Center Contract Administration System (FCAS)
Vendor Portal National Cancer Institute (NCI)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995 to provide opportunity for public comment on proposed data
collection projects, the National Institutes of Health, National Cancer
Institute (NCI) will publish periodic summaries of proposed projects to
be submitted to the Office of Management and Budget (OMB) for review
and approval.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 60 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, submit comments in writing, or
request more information on the proposed project,
[[Page 47971]]
contact: Scott Keasey, 428 Miller Drive, Suite 59 9742, Rockville, MD
20880 or call non-toll-free number 301-846-1115 or Email your request,
including your address to: [email protected]. Formal requests for
additional plans and instruments must be requested in writing.
SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: written comments and/or suggestions
from the public and affected agencies are invited to address one or
more of the following points: (1) Whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) The accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) Ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) Ways
to minimize the burden of the collection of information on those who
are to respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Proposed Collection Title: Federally Funded Research Development
Center Contract Administration System (FCAS) Vendor Portal National
Cancer Institute (NCI), 0925-0773, Expiration Date 10/31/2024,
REVISION, National Cancer Institute (NCI), National Institutes of
Health (NIH).
Need and Use of Information Collection: The National Cancer
Institute (NCI) Office of Acquisitions (OA) located within the Office
of the Director (OD) in the Office of Management (OM) at the National
Cancer Institute (NCI), awards and administers contracts and simplified
acquisitions in support of the Institute's mission to prevent, diagnose
and treat cancer. During the acquisition process, the OA ensures that
customer service is paramount, and communications are open and
continuous. Currently requests and correspondence are sent to and
received from vendors through email with the exception of the FFRDC
Contractor who submits through the FCAS Vendor Portal which is in
production. To streamline processes, increase transparency and gain
efficiencies, the OA the FCAS vendor portal to replace processes that
are handled through email FCAS Vendor Portal Users to individual OA
recipients. The FCAS Vendor Portal will serve as a one-stop shop for
transmission of requests, reports, deliverables and other
correspondence due on numerous research and development, in support of
R&D contracts as well as those contract vehicles awarded using various
Federal Acquisition Procedures including but not limited to FAR Part 8,
Required Sources of Supplies and Services, FAR Part 13, Simplified
Acquisition Procedures, and FAR Part 12, Acquisition of Commercial
Items. These reports and deliverables cover a wide variety of topics in
the areas of cancer research including prevention, detection,
diagnosis, and control.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 77.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Form name Type of Number of responses per per response Total annual
respondent respondents respondent (in hours) burden hours
----------------------------------------------------------------------------------------------------------------
Survey........................ Individuals..... 1 1 6/60 0
Registration.................. Corporations.... 1 1 6/60 0
Data Field Information........ Individuals..... 72 63 1/60 76
Add/Edit new Vendor........... Corporations.... 6 1 6/60 1
---------------------------------------------------------------------------------
Totals.................... ................ 80 4,544 .............. 77
----------------------------------------------------------------------------------------------------------------
Dated: May 30, 2024.
Diane Kreinbrink,
Project Clearance Liaison, National Cancer Institute, National
Institutes of Health.
[FR Doc. 2024-12203 Filed 6-3-24; 8:45 am]
BILLING CODE 4140-01-P
